Quanome Technologies, Inc.

Análisis de la acción Quanome Technologies, Inc. (QNME)

$0.383

+0.046 (+11.96%)Al cierre

Loading chart…
Máximo
0.386
Apertura
0.360
Precio medio ponderado por volumen
0.38
Volumen
159.27K
Capitalización
—
Mínimo
0.360
Importe
59.95K
EV/EBITDA, TTM
0.00

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

quanometech.com

Análisis de IA of Quanome Technologies, Inc. (QNME)

Vender

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Métricas de valoración

El PER previsto actual de Quanome Technologies, Inc. (QNME) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Media 5A EV/EBITDA
EV/EBITDA actual
0.00

Precio/ventas previsto

Media 5A P/S
P/S actual
0.00

Preguntas frecuentes sobre QNME, respondidas por Alphio AI

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar